Mapping the Lipid Layer of the Human Tear Film.


Journal

Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186

Informations de publication

Date de publication:
Jan 2020
Historique:
pubmed: 14 8 2019
medline: 2 6 2020
entrez: 13 8 2019
Statut: ppublish

Résumé

To describe a new method to distinguish between normal versus lipid-deficient dry eye using a Tear Film Imager (TFI). Two groups of study subjects, controls versus lipid-deficient dry eye, were tested using the TFI. This instrument provides an accurate measurement of the thickness and spatial distribution of the muco-aqueous and lipid layers of the tear film. The nanometer thickness resolution of the TFI enables the creation of detailed maps of the lipid layer thickness (LLT) across the corneal surface. These maps are captured with a large field of view of 6.5 mm diameter. A LLT map taken at 1 second from a blink end in the controls appears uniform, whereas a nonuniform layer was measured in the lipid-deficient dry eye. Lipid map uniformity can quantify the spatial variation of lipid across the cornea. A case study showed the ability to distinguish between controls [lipid map uniformity (LMU) = 14 nm] and lipid-deficient dry eye (LMU = 125 nm) through characterization of the LLT distribution. High-resolution lateral LLT maps demonstrate the significance of the lipid layer uniformity, which may play an important role in maintaining tear film health. LLT maps and the quantitative LMU could be used to diagnose and treat patients with dry eye.

Identifiants

pubmed: 31403529
doi: 10.1097/ICO.0000000000002101
pii: 00003226-202001000-00024
doi:

Substances chimiques

Lipids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

132-135

Références

Letup M, Baudouin C, Baum J. The definition and classification of dry eye disease: report of the definition and classification Subcommittee of the International Dry Eye Workshop. Ocul Surf. 2007;5:75–92.
Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15:276–283.
King-Smith PE, Hinel EA, Nichols JJ. Application of a novel interferometric method to investigate the relation between lipid layer thickness and tear film thinning. Invest Ophthalmol Vis Sci. 2010;51:2418–2423.
Hwang H, Jeon HJ, Yow KC, et al. Image-based quantitative analysis of tear film lipid layer thickness for meibomian gland evaluation. Biomed Eng Online. 2017;16:135.
King-Smith PE, Fink BA, Nichols JJ, et al. Interferometric imaging of the full thickness of the precorneal tear film. J Opt Soc Am A Opt Image Sci Vis. 2006;23:2097–2104.
King-Smith PE, Nichols JJ, Nichols KK, et al. Contributions of evaporation and other mechanisms to tear film thinning and break-up. Optom Vis Sci. 2008;85:623.
Yokoi N, Takehisa Y, Kinoshita S. Correlation of tear lipid layer interference patterns with the diagnosis and severity of dry eye. Am J Ophthalmol. 1996;122:818–824.
Goto E, Tseng SC. Differentiation of lipid tear deficiency dry eye by kinetic analysis of tear interference images. Arch Ophthalmol. 2003;121:173–180.
Szczesna-Iskander DH. Post-blink tear film dynamics in healthy and dry eyes during spontaneous blinking. Ocul Surf. 2018;16:93–100.
Arieli Y, Cohen Y, Epstein S, et al. System and method for performing tear film structure measurement. US Patent US9833139B1.
Segev F, Geffen N, Galor A, et al. Dynamic assessment of the tear film muco-aqueous and lipid layers using a novel tear film imager (TFI). Br J Ophthalmol. 2019:bjophthalmol-2018-313379.

Auteurs

Yoel Cohen (Y)

AdOM Advanced Optical Methods, Lod, Israel.

Stephen Trokel (S)

Harkness Eye Institute,Columbia University, New York, NY.

Yoel Arieli (Y)

The Jerusalem College of Technology, Jerusalem, Israel; and.

Shlomi Epshtien (S)

AdOM Advanced Optical Methods, Lod, Israel.

Raanan Gefen (R)

AdOM Advanced Optical Methods, Lod, Israel.

Alon Harris (A)

School of Medicine, Glick Eye Institute, Indiana University, Indianapolis, IN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH